PhoenixBio Co., Ltd.(JP:6190)
Â¥219.00-30.00 (-12.05%)
JP:6190
PhoenixBio Co., Ltd. financials statements
Â¥219.00
At close:-30.00 (-12.05%)
Want to see JP:6190 full AI Analyst Report?
PhoenixBio Co., Ltd. (6190) Ratios
0 Followers
PhoenixBio Co., Ltd. Ratios
JP:6190's free cash flow for Q4 2025 was ¥0.00. For the 2025 fiscal year, JP:6190's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.40 | 3.03 | 5.06 | 1.78 | 4.23 |
| Quick Ratio | 3.58 | 2.44 | 3.99 | 1.50 | 3.64 |
| Cash Ratio | 3.07 | 2.03 | 3.29 | 1.21 | 3.02 |
| Solvency Ratio | 0.25 | -0.44 | 0.06 | 0.34 | -0.21 |
| Operating Cash Flow Ratio | 0.18 | -0.13 | -0.19 | 0.22 | 0.04 |
| Short-Term Operating Cash Flow Coverage | 0.31 | -0.41 | -0.44 | 0.32 | 0.53 |
| Net Current Asset Value | ¥ 1.00B | ¥ 772.62M | ¥ 1.21B | ¥ 787.93M | ¥ 401.93M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.24 | 0.27 | 0.37 | 0.47 |
| Debt-to-Equity Ratio | 0.31 | 0.41 | 0.40 | 0.75 | 1.29 |
| Debt-to-Capital Ratio | 0.24 | 0.29 | 0.29 | 0.43 | 0.56 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.14 | 0.14 | 0.00 | 0.52 |
| Financial Leverage Ratio | 1.41 | 1.69 | 1.51 | 1.99 | 2.75 |
| Debt Service Coverage Ratio | 0.49 | -2.23 | 0.30 | 0.59 | -9.41 |
| Interest Coverage Ratio | 17.25 | -25.77 | 3.78 | 165.51 | -176.07 |
| Debt to Market Cap | 0.20 | 0.27 | 0.26 | 0.42 | 0.54 |
| Interest Debt Per Share | 120.90 | 141.08 | 192.20 | 333.55 | 324.01 |
| Net Debt to EBITDA | -5.67 | 1.47 | -7.52 | -0.79 | 0.84 |
| Profitability Margins | |||||
| Gross Profit Margin | 75.95% | 71.89% | 69.67% | 73.28% | 54.94% |
| EBIT Margin | 5.29% | -27.53% | 3.66% | 24.19% | -29.59% |
| EBITDA Margin | 7.44% | -25.70% | 5.13% | 25.30% | -23.08% |
| Operating Profit Margin | 5.29% | -8.77% | 0.64% | 23.94% | -12.65% |
| Pretax Profit Margin | 8.40% | -27.87% | 3.49% | 24.04% | -29.66% |
| Net Profit Margin | 8.00% | -28.91% | 1.54% | 23.23% | -29.28% |
| Continuous Operations Profit Margin | 8.00% | -28.91% | 1.54% | 23.23% | -29.28% |
| Net Income Per EBT | 95.27% | 103.75% | 44.12% | 96.61% | 98.72% |
| EBT Per EBIT | 158.80% | 317.80% | 540.40% | 100.43% | 234.46% |
| Return on Assets (ROA) | 5.71% | -19.29% | 0.97% | 16.34% | -17.01% |
| Return on Equity (ROE) | 8.07% | -32.64% | 1.47% | 32.57% | -46.85% |
| Return on Capital Employed (ROCE) | 4.55% | -7.75% | 0.48% | 29.35% | -9.10% |
| Return on Invested Capital (ROIC) | 3.87% | -6.91% | 0.19% | 18.55% | -8.70% |
| Return on Tangible Assets | 5.75% | -19.44% | 0.98% | 16.37% | -17.02% |
| Earnings Yield | 7.00% | -29.86% | 1.44% | 23.61% | -22.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.50 | 9.05 | 7.89 | 7.41 | 5.86 |
| Payables Turnover | 27.70 | 26.47 | 40.24 | 14.18 | 16.02 |
| Inventory Turnover | 1.22 | 1.30 | 1.15 | 1.55 | 2.31 |
| Fixed Asset Turnover | 3.02 | 2.92 | 3.16 | 3.94 | 3.23 |
| Asset Turnover | 0.71 | 0.67 | 0.63 | 0.70 | 0.58 |
| Working Capital Turnover Ratio | 1.29 | 1.08 | 1.26 | 1.75 | 0.94 |
| Cash Conversion Cycle | 316.96 | 307.25 | 353.32 | 258.39 | 197.41 |
| Days of Sales Outstanding | 31.73 | 40.32 | 46.27 | 49.27 | 62.34 |
| Days of Inventory Outstanding | 298.41 | 280.71 | 316.12 | 234.87 | 157.85 |
| Days of Payables Outstanding | 13.17 | 13.79 | 9.07 | 25.75 | 22.78 |
| Operating Cycle | 330.14 | 321.04 | 362.39 | 284.14 | 220.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 16.94 | -18.05 | -20.97 | 81.69 | 4.97 |
| Free Cash Flow Per Share | 13.88 | -23.30 | -31.22 | 78.05 | 2.92 |
| Dividend Paid and CapEx Coverage Ratio | 5.54 | -3.44 | -2.05 | 22.44 | 2.42 |
| Capital Expenditure Coverage Ratio | 5.54 | -3.44 | -2.05 | 22.44 | 2.42 |
| Operating Cash Flow Coverage Ratio | 0.14 | -0.13 | -0.11 | 0.25 | 0.02 |
| Operating Cash Flow to Sales Ratio | 0.04 | -0.05 | -0.05 | 0.13 | 0.01 |
| Free Cash Flow Yield | 3.15% | -6.31% | -6.45% | 12.69% | 0.56% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.28 | -3.35 | 69.39 | 4.23 | -4.46 |
| Price-to-Sales (P/S) Ratio | 1.14 | 0.97 | 1.07 | 0.98 | 1.31 |
| Price-to-Book (P/B) Ratio | 1.15 | 1.09 | 1.02 | 1.38 | 2.09 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 31.70 | -15.84 | -15.50 | 7.88 | 179.73 |
| Price-to-Operating Cash Flow Ratio | 25.97 | -20.44 | -23.08 | 7.53 | 105.51 |
| Price-to-Earnings Growth (PEG) Ratio | -0.11 | 0.00 | -0.73 | -0.02 | -0.07 |
| Enterprise Value Multiple | 9.68 | -2.29 | 13.30 | 3.10 | -4.82 |
| Enterprise Value | 1.13B | 908.45M | 1.17B | 1.66B | 1.47B |
| EV to EBITDA | 9.68 | -2.29 | 13.30 | 3.10 | -4.82 |
| EV to Sales | 0.72 | 0.59 | 0.68 | 0.78 | 1.11 |
| EV to Free Cash Flow | 19.99 | -9.64 | -9.90 | 6.28 | 153.07 |
| EV to Operating Cash Flow | 16.38 | -12.44 | -14.75 | 6.00 | 89.87 |
| Tangible Book Value Per Share | 378.29 | 333.07 | 472.45 | 444.30 | 250.35 |
| Shareholders’ Equity Per Share | 381.97 | 337.58 | 475.34 | 445.84 | 250.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.05 | -0.04 | 0.56 | 0.03 | 0.01 |
| Revenue Per Share | 385.15 | 381.09 | 453.58 | 625.29 | 401.22 |
| Net Income Per Share | 30.81 | -110.18 | 6.98 | 145.23 | -117.50 |
| Tax Burden | 0.95 | 1.04 | 0.44 | 0.97 | 0.99 |
| Interest Burden | 1.59 | 1.01 | 0.95 | 0.99 | 1.00 |
| Research & Development to Revenue | 0.12 | 0.18 | 0.12 | 0.10 | 0.17 |
| SG&A to Revenue | 0.58 | 0.63 | 0.09 | 0.07 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Income Quality | 0.55 | 0.16 | -3.05 | 0.56 | -0.04 |
Currency in JPY
